VMP 15621411000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets
BNF code 0604011Q0AAAHAH
Virtual Therapeutic Moiety Conjugated oestrogens + Medroxyprogesterone
Date identifier became valid 29 Jun 2009
Previous product identifier 409319007
Abbreviated name Conj oestrogens 300microg/Medroxyprogesterone 1.5mg MR tab
Basis of preferred name Other
Date of name applicability 25 Jun 2010
Previous name Medroxyprogesterone 1.5mg / Conjugated oestrogens 300microgram modified-release tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Conjugated oestrogens
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 300.000
Strength value numerator unit microgram
Virtual Product Ingredient
Ingredient Medroxyprogesterone acetate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 1.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Premique Low Dose 0.3mg/1.5mg modified-release tablets (Pfizer Ltd)
Virtual Medicinal Product Packs
Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_8.1.0_20220808000001, imported on 8th August 2022 at 04:49:10.